# Hepatitis A beyond childhood causing diagnostic and therapeutic challenges in Addis Ababa, Ethiopia

**Authors:** Abate Bane Shewaye, Kaleb Assefa Berhane, Amsalework Daniel Fanta

PMC · DOI: 10.1371/journal.pone.0330212 · PLOS One · 2025-08-13

## TL;DR

This study highlights the rising cases of hepatitis A among teenagers and young adults in Addis Ababa, often misdiagnosed as other conditions, stressing the need for better awareness and accurate testing.

## Contribution

The study documents a shift in hepatitis A susceptibility to adolescents and young adults and emphasizes misdiagnosis challenges in this demographic.

## Key findings

- The mean age of patients was 19.3 years, showing a shift in HAV susceptibility to adolescents and young adults.
- Over half of the patients were initially misdiagnosed with typhoid fever, peptic ulcer disease, or urinary tract infection.
- All patients recovered fully with supportive care within 2–4 weeks, with normalized liver function tests.

## Abstract

Hepatitis A is an acute viral infection of the liver caused by hepatitis A virus (HAV) that is acquired through the feco-oral route. It has the highest incidence among the four major acute viral hepatitis types (A, B, C, and E) and usually occurs in early childhood. However, the prevalence of acute hepatitis A has recently increased among teenagers and young adults, and it is usually misdiagnosed. This study emphasizes the significance of awareness among healthcare workers about the increasing incidence of acute hepatitis A among this group to ensure accurate diagnosis and appropriate management.

A hospital-based retrospective cross-sectional study was employed. Fifty-eight confirmed acute HAV patients who visited Adera Medical and Surgical Center (AMSC) between August 2023 and January 2024 were enrolled. Sociodemographic, clinical, and laboratory parameters and documented management data, including hospitalization and any trial of antibiotic treatment before considering HAV or in the course of the illness, were collected. The data were entered and analyzed using SPSS (SPSS, Version 26.0).

The sex ratio was similar, with a slight male predominance (M/F = 1.07). The mean age [± SD] of the patients was 19.3[± 8.8] years. Thirty-nine (67.2%) of the patients were students, and all of the patients were from Addis Ababa. Vomiting (82.8%), anorexia (70.7%) and yellowish discoloration of the eyes (62.1%) were the most common presenting symptoms, while icteric sclera 44 (75.9%) and epigastric tenderness 17 (29.3%) were the most common physical findings. More than half of the patients (55.2%) were initially misdiagnosed with typhoid fever (TF) (46.8%), peptic ulcer disease (PUD) (31.2%) or urinary tract infection (UTI) (15.6%). All patients recovered fully, and liver function tests (LFTs) normalized with supportive care within 2–4 weeks.

This study revealed the shift in the age of HAV susceptibility and subsequent infection towards adolescents and young adults (mean [± SD] age 19.31 [± 8.8] years) in our cohort, with more than half of the patients (55.2%) initially being misdiagnosed with TF, PUD or UTI, causing diagnostic and treatment challenges. This necessitates heightened awareness among healthcare workers and the public. Early HAV diagnosis through targeted laboratory investigations and avoiding unnecessary antibiotics are crucial for effective management and prevention via hygienic and immunization strategies.

## Linked entities

- **Diseases:** hepatitis A (MONDO:0005790), typhoid fever (MONDO:0005619), peptic ulcer disease (MONDO:0004247), urinary tract infection (MONDO:0005247)

## Full-text entities

- **Genes:** ATHS (atherosclerosis susceptibility (lipoprotein associated)) [NCBI Gene 470] {aka ALP}, SLC17A5 (solute carrier family 17 member 5) [NCBI Gene 26503] {aka AST, ISSD, NSD, SD, SIALIN, SIASD}
- **Diseases:** PUD (MESH:D010437), liver injury (MESH:D017093), epigastric tenderness (MESH:D063806), Hepatomegaly (MESH:D006529), fever (MESH:D005334), diarrhea (MESH:D003967), abdominal discomfort (MESH:D000007), acute (MESH:D000208), inflammation of the liver (MESH:D007249), death (MESH:D003643), Autoimmune hepatitis (MESH:D019693), hepatic hemangioma (MESH:D006391), Hepatitis A (MESH:D056486), acute cholecystitis (MESH:D041881), Fatty liver (MESH:D005234), Vomiting (MESH:D014839), Leukocytosis (MESH:D007964), UTI (MESH:D014552), viral hepatitis (MESH:D014777), HAV (MESH:D006525), acute hepatitis (MESH:D017114), infected (MESH:D007239), jaundice (MESH:D007565), enteric virus infection (MESH:D004751), splenomegaly (MESH:D013163), anorexia (MESH:D000855), gallstone disease (MESH:D002769), arthralgia (MESH:D018771), TF (MESH:D014435), AMSC (MESH:D007431)
- **Chemicals:** phosphatidylcholine (MESH:D010713), cotrimoxazole (MESH:D015662), bilirubin (MESH:D001663), cefixime (MESH:D020682), Ciprofloxacillin (-), ceftriaxone (MESH:D002443), ciprofloxacin (MESH:D002939), doxycycline (MESH:D004318), vitamin E (MESH:D014810)
- **Species:** Hepatovirus A (no rank) [taxon 12092], Homo sapiens (human, species) [taxon 9606], Human immunodeficiency virus 1 (no rank) [taxon 11676]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12349081/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12349081/full.md

## References

18 references — full list in the complete paper: https://tomesphere.com/paper/PMC12349081/full.md

---
Source: https://tomesphere.com/paper/PMC12349081